電科芯片(600877.SH):子公司被美國商務部列入實體清單
格隆匯3月26日丨電科芯片(600877.SH)公佈,公司近日關注到,美國商務部工業和安全局於當地時間2025年3月26日發佈了“實體清單”,公司子公司重慶西南集成電路設計有限責任公司(簡稱“西南設計”)被列入其中。根據美國《出口管理條例》的規定,供應商向“實體清單”企業銷售EAR管制物項,需要事先向美國商務部申請出口許可證。目前西南設計各項業務穩步推進,經營及財務情況正常,本次被列入“實體清單”不會對西南設計業務產生實質性影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.